FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1532952219> ?p ?o ?g. }

• W1532952219 abstract "It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent autoimmunity (before the onset of symptoms), on the development of RA.Blood samples donated to the Medical Biobank of Northern Sweden from individuals prior to the onset of symptoms of RA (n=370) and after onset (n=203) and from population-based controls (n=585) were used. Antibodies against 10 citrullinated peptides, fibrinogen (Fibα561-583, α580-600, ß62-81a, ß62-81b, ß36-52), vimentin (Vim2-17, 60-75), filaggrin (CCP-1/Fil307-324), α-enolase (CEP-1/Eno5-21), collagen type II (citC1359-369), and anti-cyclic citrullinated peptide (CCP)2 antibodies were analysed.HLA-SE-positive individuals were more frequently positive for ACPA compared with HLA-SE-negative individuals prior to the onset of symptoms of RA, particularly for antibodies against CEP-1 and Fibß62-81a (72). Smoking was associated with antibodies against Vim2-17 and citC1359-369. HLA-SE and smoking showed increasing association to the presence of the antibodies closer to disease onset. The highest odds ratio (OR) for development of RA was for the combination of HLA-SE alleles and ACPA positivity, especially for antibodies against Fibß62-81b, CCP-1/Fil307-324, and Fibβ36-52. A gene-environment additive interaction between smoking and HLA-SE alleles for the risk of disease development was found, with the highest OR for individuals positive for antibodies against Fibβ36-52, CEP-1, and Fibα580-600.The relationships between antibodies against the different ACPA specificities, HLA-SE, and smoking showed a variable pattern in individuals prior to the onset of RA. The combination of smoking and HLA-SE alleles was significantly associated with the development of some of the antibody specificities closer to onset of symptoms, and these associations remained significant at diagnosis. An additive gene-environment interaction was found for several of the antibodies for the development of RA." @default.
• W1532952219 created "2016-06-24" @default.
• W1532952219 creator A5002472722 @default.
• W1532952219 creator A5010629312 @default.
• W1532952219 creator A5041340587 @default.
• W1532952219 creator A5045980530 @default.
• W1532952219 creator A5065334695 @default.
• W1532952219 creator A5071491614 @default.
• W1532952219 creator A5084836838 @default.
• W1532952219 creator A5087811228 @default.
• W1532952219 creator A5088690481 @default.
• W1532952219 date "2015-05-20" @default.
• W1532952219 modified "2023-10-05" @default.
• W1532952219 title "Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis" @default.
• W1532952219 cites W1675454661 @default.
• W1532952219 cites W1913865297 @default.
• W1532952219 cites W1964890547 @default.
• W1532952219 cites W1989515097 @default.
• W1532952219 cites W2014872947 @default.
• W1532952219 cites W2024988150 @default.
• W1532952219 cites W2025408360 @default.
• W1532952219 cites W2039684625 @default.
• W1532952219 cites W2056438883 @default.
• W1532952219 cites W2100068629 @default.
• W1532952219 cites W2101038560 @default.
• W1532952219 cites W2107005433 @default.
• W1532952219 cites W2111608476 @default.
• W1532952219 cites W2115421086 @default.
• W1532952219 cites W2115694552 @default.
• W1532952219 cites W2116750865 @default.
• W1532952219 cites W2124313950 @default.
• W1532952219 cites W2127818570 @default.
• W1532952219 cites W2132941752 @default.
• W1532952219 cites W2152348310 @default.
• W1532952219 cites W4231236597 @default.
• W1532952219 doi "https://doi.org/10.1186/s13075-015-0638-x" @default.
• W1532952219 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4438519" @default.
• W1532952219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25990747" @default.
• W1532952219 hasPublicationYear "2015" @default.
• W1532952219 type Work @default.
• W1532952219 sameAs 1532952219 @default.
• W1532952219 citedByCount "42" @default.
• W1532952219 countsByYear W15329522192015 @default.
• W1532952219 countsByYear W15329522192016 @default.
• W1532952219 countsByYear W15329522192017 @default.
• W1532952219 countsByYear W15329522192018 @default.
• W1532952219 countsByYear W15329522192019 @default.
• W1532952219 countsByYear W15329522192020 @default.
• W1532952219 countsByYear W15329522192021 @default.
• W1532952219 countsByYear W15329522192022 @default.
• W1532952219 countsByYear W15329522192023 @default.
• W1532952219 crossrefType "journal-article" @default.
• W1532952219 hasAuthorship W1532952219A5002472722 @default.
• W1532952219 hasAuthorship W1532952219A5010629312 @default.
• W1532952219 hasAuthorship W1532952219A5041340587 @default.
• W1532952219 hasAuthorship W1532952219A5045980530 @default.
• W1532952219 hasAuthorship W1532952219A5065334695 @default.
• W1532952219 hasAuthorship W1532952219A5071491614 @default.
• W1532952219 hasAuthorship W1532952219A5084836838 @default.
• W1532952219 hasAuthorship W1532952219A5087811228 @default.
• W1532952219 hasAuthorship W1532952219A5088690481 @default.
• W1532952219 hasBestOaLocation W15329522191 @default.
• W1532952219 hasConcept C126322002 @default.
• W1532952219 hasConcept C147483822 @default.
• W1532952219 hasConcept C159654299 @default.
• W1532952219 hasConcept C163764329 @default.
• W1532952219 hasConcept C188280979 @default.
• W1532952219 hasConcept C195616568 @default.
• W1532952219 hasConcept C198451711 @default.
• W1532952219 hasConcept C203014093 @default.
• W1532952219 hasConcept C2776232647 @default.
• W1532952219 hasConcept C2777077863 @default.
• W1532952219 hasConcept C2777575956 @default.
• W1532952219 hasConcept C2908647359 @default.
• W1532952219 hasConcept C71924100 @default.
• W1532952219 hasConcept C99454951 @default.
• W1532952219 hasConceptScore W1532952219C126322002 @default.
• W1532952219 hasConceptScore W1532952219C147483822 @default.
• W1532952219 hasConceptScore W1532952219C159654299 @default.
• W1532952219 hasConceptScore W1532952219C163764329 @default.
• W1532952219 hasConceptScore W1532952219C188280979 @default.
• W1532952219 hasConceptScore W1532952219C195616568 @default.
• W1532952219 hasConceptScore W1532952219C198451711 @default.
• W1532952219 hasConceptScore W1532952219C203014093 @default.
• W1532952219 hasConceptScore W1532952219C2776232647 @default.
• W1532952219 hasConceptScore W1532952219C2777077863 @default.
• W1532952219 hasConceptScore W1532952219C2777575956 @default.
• W1532952219 hasConceptScore W1532952219C2908647359 @default.
• W1532952219 hasConceptScore W1532952219C71924100 @default.
• W1532952219 hasConceptScore W1532952219C99454951 @default.
• W1532952219 hasIssue "1" @default.
• W1532952219 hasLocation W15329522191 @default.
• W1532952219 hasLocation W15329522192 @default.
• W1532952219 hasLocation W15329522193 @default.
• W1532952219 hasLocation W15329522194 @default.
• W1532952219 hasLocation W15329522195 @default.
• W1532952219 hasLocation W15329522196 @default.
• W1532952219 hasOpenAccess W1532952219 @default.
• W1532952219 hasPrimaryLocation W15329522191 @default.
• W1532952219 hasRelatedWork W1595313286 @default.

• next